This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mayer, A. Articles by Fabien, N. Search for Related Content PubMed PubMed Citation Articles by Mayer, A. Articles by Fabien, N.

Calcium-Sensing Receptor Autoantibodies Are Relevant Markers of Acquired Hypoparathyroidism

Laboratoire d’Immunologie, Unité Fonctionnelle d’Auto-Immunité, Centre Hospitalier Lyon-Sud (C.P., A.D., A.M., J.-C.M., J.B., N.F.), 69495 Pierre-Benite, France; and Institut National de la Santé et de la Recherche Médicale, Unité 449, Faculté Laënnec (A.M., J.O., H.V.), 69008 Lyon, France

Address all correspondence and requests for reprints to: Dr. Nicole Fabien, Unité Fonctionnelle d’Auto-Immunité, Centre Hospitalier Lyon-Sud, 69495 Pierre-Benite Cedex, France. E-mail: nicole.fabien{at}chu-lyon.fr

We investigated the presence of autoantibodies (aAbs) directed against the parathyroid gland in 17 patients with spontaneous isolated acquired hypoparathyroidism. Fourteen patients with acquired hypoparathyroidism (AH) associated with type I or II autoimmune polyendocrinopathy syndrome were also tested in comparison with a control group of 68 subjects without AH, including patients with other autoimmune diseases and healthy blood donors. aAbs against parathyroid tissue were screened using an indirect immunofluorescence technique on primate parathyroid tissue and human parathyroid adenoma. aAbs against the calcium-sensing receptor (CaSR) were analyzed using an immunoblotting assay with the recombinant extracellular domain of the human CaSR as antigen. Seven of the 31 patients with AH were positive for CaSR aAbs. Five of the positive sera were obtained from the group with isolated AH. The two other positive sera were from patients with autoimmune polyendocrinopathy syndrome. The sensitivity of the immunoblotting technique was higher than that of both the radioimmunological test using the extracellular domain of the CaSR and the indirect immunofluorescence technique. There were no positive sera in the control group. In conclusion, using an immunoblotting assay, we demonstrate the presence of CaSR aAbs in about one third of the patients with isolated AH, pointing out the value of detecting such aAbs to assess the autoimmune origin of the disease.

This article has been cited by other articles:

				N. G. Gavalas, E. H. Kemp, K. J. E. Krohn, E. M. Brown, P. F. Watson, and A. P. Weetman The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2107 - 2114. [Abstract] [Full Text] [PDF]

				R. Goswami, R. K. Marwaha, D. Goswami, N. Gupta, D. Ray, N. Tomar, and S. Singh Prevalence of Thyroid Autoimmunity in Sporadic Idiopathic Hypoparathyroidism in Comparison to Type 1 Diabetes and Premature Ovarian Failure J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4256 - 4259. [Abstract] [Full Text] [PDF]